lobbying_activities: 3243708
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3243708 | 101b59ad-1200-4e42-b28c-38372cad25f4 | 3T | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC | 17966 | EMERGENT BIOSOLUTIONS | 2024 | third_quarter | DIS | Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2024-10-17T13:55:53-04:00 |